Article Text

PDF
Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2
  1. Alide A Tieleman1,
  2. Hans Knoop2,
  3. Anne-Els van de Logt1,
  4. Gijs Bleijenberg2,
  5. Baziel G M van Engelen1,
  6. Sebastiaan Overeem1,3
  1. 1Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  2. 2Expert Centre Chronic Fatigue, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  3. 3Centre for Sleep Medicine ‘Kempenhaeghe’, Heeze, The Netherlands
  1. Correspondence to Dr S Overeem, Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands; s.overeem{at}neuro.umcn.nl

Abstract

Background In myotonic dystrophy type 1 (DM1), sleep disorders are common, with excessive daytime sleepiness (EDS) as a predominant feature. In myotonic dystrophy type 2 (DM2), the presence of sleep disturbances is unknown.

Objective To investigate the frequency of EDS, poor sleep quality and fatigue in DM2.

Methods 29 genetically proven DM2 patients were surveyed using the Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index (PSQI) and Checklist Individual Strength. The results were compared with 29 adult onset DM1 patients and 65 population controls, both matched for age and sex.

Results Only 6.9% of DM2 patients had EDS compared with 44.8% of DM1 patients and 6.2% of population controls (DM2–DM1: p=0.001; DM2–controls: p=0.51). Sleep quality was poor (PSQI >5) in both DM2 and DM1 groups, and differed significantly from population controls (DM2 6.5±3.0; DM1 6.2±3.7; controls 4.3±3.0; DM2–controls: p=0.002). Poor sleep quality was not explained by depression or other comorbidity but was mainly due to sleep disturbances as a result of nocturnal pain. Comparable with the DM1 group, DM2 patients experienced severe fatigue (DM2 38.7±13.1; DM1 42.9±8.5; controls 21.1±11.1; DM2–controls: p<0.001). Results were not confounded by abnormal thyroid function or medication use.

Conclusion These results provide new insight into the phenotype of DM2 and have consequences for clinical treatment. In addition, the absence of EDS in DM2 is a new discriminative feature with adult onset DM1.

  • Myotonic dystrophy
  • sleep
  • sleep disorders

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Ethics approval The study was approved by the local ethics committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.